QUALITY IMPROVEMENT CASE STUDY
From Medication Discrepancies to Safety
Patients with Chronic Kidney Disease and End-Stage Renal Disease often manage complex medication regimens that increase their risk of discrepancies, adverse drug events, and preventable clinical harm.
This quality-improvement case study examines a pharmacist-led medication reconciliation service embedded within a Chronic Care Management program at a large nephrology practice operating across seven clinics.
Over four months, clinical pharmacists reviewed 9,023 medications for 531 Medicare beneficiaries and identified 1,459 medication discrepancies, representing a 16.2% medication-level discrepancy rate. The program also achieved a Net Promoter Score of 82 and produced estimated cost avoidance ranging from $76,995 to $310,635.
Download the case study to learn how structurally integrating clinical pharmacists into nephrology care teams can improve medication accuracy, strengthen patient safety, increase patient trust, and reduce medication-related costs.
- How pharmacist-led medication reconciliation identified 1,459 medication discrepancies across 531 Medicare beneficiaries
- Why 48.4% of patients had at least one medication discrepancy during the study period
- How clinical pharmacists reviewed 9,023 medications across seven nephrology clinic sites
- How the program achieved a Net Promoter Score of 82
- How pharmacist-led interventions generated estimated cost avoidance of $76,995 to $310,635 over four months
